Adhera Therapeutics Statistics

Total Valuation

Adhera Therapeutics has a market cap or net worth of 1,163. The enterprise value is 10.80 million.

Market Cap	1,163
Enterprise Value	10.80M

Important Dates

The next estimated earnings date is Monday, April 7, 2025.

Earnings Date	Apr 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Adhera Therapeutics has 11.63 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	11.63M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-95.63%
Owned by Insiders (%)	3.72%
Owned by Institutions (%)	0.00%
Float	10.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio	0.00
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-532.88%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-2.31M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.60% in the last 52 weeks. The beta is 3.37, so Adhera Therapeutics's price volatility has been higher than the market average.

Beta (5Y)	3.37
52-Week Price Change	-99.60%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	14.59
Average Volume (20 Days)	16,507

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.00

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.28M
Pretax Income	-4.49M
Net Income	-4.61M
EBITDA	n/a
EBIT	-1.28M
Earnings Per Share (EPS)	-1.31

Full Income Statement

Balance Sheet

The company has 32,388 in cash and 10.83 million in debt, giving a net cash position of -10.80 million or -0.93 per share.

Cash & Cash Equivalents	32,388
Total Debt	10.83M
Net Cash	-10.80M
Net Cash Per Share	-0.93
Equity (Book Value)	-26.32M
Book Value Per Share	-5.09
Working Capital	-26.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-714,193
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adhera Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-104.10%
Shareholder Yield	-104.10%
Earnings Yield	-396,453.48%
FCF Yield	n/a

Stock Splits

The last stock split was on October 6, 2022. It was a reverse split with a ratio of 0.05.

Last Split Date	Oct 6, 2022
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a